Proportion and Characteristics of US Adults Who May Be Eligible From Additional Blood Pressure Lowering Based on Absolute Risk
The Systolic Blood Pressure Intervention Trial (SPRINT) and the Heart Outcomes Prevention Evaluation 3 (HOPE-3) trial demonstrated the merits of blood pressure (BP) lowering to reduce cardiovascular events in intermediate to high cardiovascular risk adults. However, the population impact of an absolute risk-based strategy for BP lowering remains unclear.
We examined 3 treatment thresholds using the National Health and Nutrition Examination Survey. First,...
- Publication status:
- Peer review status:
- Peer reviewed
(Accepted manuscript, pdf, 130.0KB)
- Publisher copy:
- Copyright holder:
- American Journal of Hypertension
- Copyright date:
- © American Journal of Hypertension, Ltd 2016. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from OUP at: [10.1093/ajh/hpw130]
If you are the owner of this record, you can report an update to it here: Report update to this record